FDA Begins New Safety Review of RSV Antibody Treatments for Infants

  U.S. health regulators have launched a renewed safety examination of approved respiratory syncytial virus (RSV) preventive treatments for infants, according to sources familiar with the matter. Senior officials at pharmaceutical companies Merck, Sanofi, and AstraZeneca were informed last week that their RSV products would undergo additional scrutiny, despite already receiving regulatory approval. The therapies […]

Continue Reading

Childhood Vaccination Success at Risk: Study Warns of Global Setbacks

  Over the last 50 years, routine childhood vaccines have saved an estimated 154 million young lives worldwide, according to a comprehensive study published in The Lancet. The success is largely credited to the World Health Organization’s Expanded Programme on Immunization, which has reached over 4 billion children globally. Despite this historic achievement, recent data […]

Continue Reading

FDA Advisory Panel Backs Broad Flexibility in COVID-19 Vaccine Updates

  A panel of scientific experts advising the U.S. Food and Drug Administration (FDA) has unanimously recommended a flexible approach for this year’s COVID-19 vaccines. This allows the agency to retain the current vaccine composition or update it to better match the variants currently in circulation. Concerns Over New Vaccine Approval Framework During the advisory […]

Continue Reading